You have 9 free searches left this month | for more free features.

Condition

Atherosclerotic Cardiovascular Disease (1)

Elevated Serum Lipoprotein(a) (1)

Hepatic Impairment (1)

Renal Impairment (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (3)

phase 3 (1)

Sponsor

Amgen (4)

Collaborator

Intervention

olpasiran (4)

placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (4)

Study Type

Interventional (4)

olpasiran

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatic Impairment Trial (Olpasiran)

Not yet recruiting

Hepatic Impairment

Olpasiran

(no location specified)

Jul 28, 2022

Renal Impairment Trial (Olpasiran)

Not yet recruiting

Renal Impairment

Olpasiran

(no location specified)

Aug 3, 2022

Elevated Serum Lipoprotein(a) Trial in Hong Kong (Olpasiran)

Completed

Elevated Serum Lipoprotein(a)

Olpasiran

Hong Kong, HK, Hong Kong

Queen Mary Hospital

Mar 30, 2022

Atherosclerotic Cardiovascular Disease Trial in Worldwide (Placebo, Olpasiran)

Recruiting

Atherosclerotic Cardiovascular Disease

Placebo
Olpasiran

Huntsville, Alabama
+83 more

Feb 1, 2023